Skip to main content
OpenTrials
Completed

NCT Number: NCT02414919

Duration of Use of Highly Effective Reversible Contraception

To assess the proportion of women who use HERC for ≥2 years of duration

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

15 year–44 year

Sex eligibility

Female

Study type

Observational

Primary location

Salt Lake City, Utah, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

-Women who had an IUD or contraceptive implant inserted and removed within the University of Utah from January 1, 2004 to October 31, 2012

Treatment and study plan

Mirena (Levonorgestrel IUS, BAY86-5028)

Drug

Levonorgestrel-releasing intrauterine device 20 mcg/day

ParaGard

Drug

Copper T380A

Implanon/Nexplanon

Drug

Etonorgestrel contraceptive implant

Primary outcomes

  1. Proportion of women who use HERC

    Time frame: 2 years post-HERC initiation

Secondary outcomes

  1. Duration of real world use of three different HERC devices

    Time frame: 2 years post-HERC initiation

Other outcomes

  1. Difference in patient characteristics of women who chose different HERC devices

    Time frame: 2 years post-HERC initiation

  2. Proportion of HERC used for ≥3 years of duration

    Time frame: ≥3 years post-HERC initiation

  3. Model the predictors of ≥3 years of duration

    Time frame: ≥3 years post-HERC initiation

Sponsors and collaborators

Lead sponsor

Bayer

Industry

Collaborators

  • University of Utah

Registry information

Official study title

Real-world Duration of Use for Highly Effective Reversible Contraception (HERC): A Retrospective Review

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Apr 13, 2015
Registry last updated
Mar 16, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.